This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: H. Lundbeck A/s, Vernalis &r&d) Ltd.. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 513 
1 out of 68 
Years Active: 2016-2017
Title: Yikang Wang: Innovator in LRRK2 Inhibitors
Introduction
Yikang Wang is a notable inventor based in Winnersh, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target LRRK2, a protein associated with various neurodegenerative diseases.
Latest Patents
Yikang Wang holds 2 patents related to arylpyrrolopyridine derived compounds as LRRK2 inhibitors. His inventions focus on arylpyrrolopyridine derivatives of Formula A, which are considered useful for treating diseases associated with LRRK2, such as Lewy body dementia, Parkinson's disease, and cancer. These compounds represent a promising avenue for therapeutic intervention in these challenging conditions.
Career Highlights
Throughout his career, Yikang Wang has worked with reputable companies, including H. Lundbeck A/S and Vernalis R&D Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Yikang has collaborated with esteemed colleagues, including Simon Bedford and I-Jen Chen, enhancing the research and development efforts in his field.
Conclusion
Yikang Wang's innovative work in developing LRRK2 inhibitors showcases his commitment to addressing critical health challenges. His contributions to medicinal chemistry are paving the way for potential treatments for neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile